Cefdinir and Nystop drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cefdinir (cefdinir) and Nystop (nystatin). Common drug interactions include urinary tract infection among females and abdominal pain among males.
The phase IV clinical study analyzes what interactions people have when they take Cefdinir and Nystop. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.
What is Cefdinir?
Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.
What is Nystop?
Nystop has active ingredients of nystatin. eHealthMe is studying from 1,310 Nystop users. Check the latest studies of Nystop.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
24 people who take Cefdinir and Nystop together, and have interactions are studied.

What are the common drug interactions of Cefdinir and Nystop, by gender? *:
female:
- Urinary tract infection
- Dyspnoea (difficult or laboured respiration)
- Back pain
- Fatigue (feeling of tiredness)
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Subcutaneous abscess
- Abscess (pus)
- Abscess limb (limb infection)
- Alopecia (absence of hair from areas of the body)
- Cellulitis (infection under the skin)
male:
- Abdominal pain
- Cardiac disorder
- Pain in extremity
- Procedural site reaction
- Pulmonary embolism (blockage of the main artery of the lung)
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Subcutaneous abscess
- Subcutaneous haematoma (collection of blood outside the blood vessels on the skin)
- Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
- Atelectasis (partial or complete collapse of the lung)
What are the common drug interactions of Cefdinir and Nystop, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Epistaxis (bleed from the nose)
- Eyelid margin crusting (crusting at the lid margins, generally worse on waking)
- Hypersomnia (excessive daytime sleepiness (eds))
- Rash pruritic (redness with itching)
- Weight decreased
30-39:
n/a
40-49:
- Subcutaneous abscess
- Abscess (pus)
- Abscess limb (limb infection)
- Cellulitis (infection under the skin)
- Escherichia sepsis (bacterial infection by escherichia coli)
- Groin abscess (pus in groin)
- Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
- Perineal abscess
- Perirectal abscess
- Sepsis (a severe blood infection that can lead to organ failure and death)
50-59:
n/a
60+:
- Dyspnoea (difficult or laboured respiration)
- Back pain
- White blood cell count decreased
- Chest discomfort
- Cough
- Dehydration (dryness resulting from the removal of water)
- Discomfort
- Gout (uric acid crystals building up in the body)
- Idiopathic pulmonary fibrosis (chronic lung disease)
- Infusion related reaction
What are the existing conditions these people have? *
- Pain: 4 people, 16.67%
- Multiple Myeloma (cancer of the plasma cells): 4 people, 16.67%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 4 people, 16.67%
- Stress And Anxiety: 3 people, 12.50%
- Weight Decreased: 2 people, 8.33%
- Type 2 Diabetes: 2 people, 8.33%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 8.33%
- Nausea (feeling of having an urge to vomit): 2 people, 8.33%
- Hypersensitivity: 2 people, 8.33%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Cefdinir and Nystop?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Cefdinir and Nystop:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cefdinir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Nystop:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefdinir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nystop and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cefdinir and nystatin (the active ingredients of Cefdinir and Nystop, respectively), and Cefdinir and Nystop (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Azelastine and Sodium Bicarbonate - now
- Could Temaz cause Withdrawal Syndrome? - 8 seconds ago
- Drug interactions of Ergocalciferol and Cabometyx - 12 seconds ago
- Drug interactions of Bystolic and Vitamins - 22 seconds ago
- Could Aredia cause Procedural Complication? - 22 seconds ago
- Could Doxorubicin Hydrochloride cause Dyspnea Exacerbated? - 22 seconds ago
- Could Terazosin Hydrochloride cause Abdominal Pain Aggravated? - 24 seconds ago
- Drug interactions of Verapamil Hydrochloride and Lovenox - 27 seconds ago
- Drug interactions of Aspirin and Piperacillin - 28 seconds ago
- Drug interactions of Jakafi and Restasis - 33 seconds ago